# IBO (Impact BioMedical, INC.) - SEC EDGAR Financial Statements

> Impact BioMedical, INC. reported $32K in revenue and net income of $1.61M for the fiscal year ended December 31, 2025, with a -1225.0% gross margin and a -15028.1% operating margin.

- Canonical: https://convexityos.com/fundamentals/IBO
- Markdown: https://convexityos.com/fundamentals/IBO.md
- SEC CIK: 0001834105
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:00 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001834105&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $32K | Dec 31, 2025 |
| Operating Income | FY 2025 | -$4.81M | -15028.1% margin |
| Net Income | FY 2025 | $1.61M | 5043.8% net margin |
| Diluted EPS | FY 2025 | -$4.85 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $21K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $32K | -- | -- | $50K |
| Cost of Revenue | $424K | -- | -- | -- |
| **Gross Profit** | -$392K | -- | -- | -- |
| Research & Development | $340K | $278K | $1.69M | $1.23M |
| Selling, General & Admin | $873K | $718K | $315K | $325K |
| Total Operating Expenses | -- | $28.75M | $4.03M | -- |
| **Operating Income** | -$4.28M | -$28.75M | -$4.03M | -$3.40M |
| **EBITDA** | -$3.14M | -$27.63M | -$2.91M | -$2.29M |
| Interest Income | -- | -- | $13K | $24K |
| Interest Expense | $793K | $1.06M | $444K | $462K |
| Income Before Tax | -$14.45M | -$24.74M | -$4.41M | -$7.88M |
| Income Tax Expense | -$2.58M | $33K | -- | -$621K |
| **Net Income** | -$11.84M | -$24.71M | -$4.34M | -$7.25M |
| Basic EPS | -$4.85 | -$29.37 | -$0.89 | -$1.28 |
| **Diluted EPS** | -$4.85 | -$29.37 | -$0.89 | -$1.28 |
| Basic Shares Outstanding | 2.5M | 842.3K | 4.7M | 5.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $21K | $3.0K | $7.0K | -- | $18K | $7.0K | -- | -- |
| Cost of Revenue | $6.0K | $1.0K | -- | -- | $1.0K | $1.0K | -- | -- |
| **Gross Profit** | $15K | $2.0K | -- | -- | $17K | $6.0K | -- | -- |
| Research & Development | $35K | $76K | $46K | $110K | $52K | $75K | $103K | -$108K |
| Selling, General & Admin | $156K | $167K | $1.62M | $118K | $261K | $246K | $248K | $294K |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $1.01M | $26.23M |
| **Operating Income** | -$648K | -$702K | -$2.29M | -$1.17M | -$948K | -$1.15M | -$1.01M | -$26.23M |
| **EBITDA** | -$364K | -$418K | -$2.00M | -$884K | -$660K | -$865K | -$727K | -$25.95M |
| Interest Income | $4.0K | $2.0K | $5.0K | -- | $3.0K | $3.0K | $3.0K | -- |
| Interest Expense | -- | -- | -- | $0 | $262K | $260K | $271K | $270K |
| Income Before Tax | -$644K | -$700K | -$2.28M | $2.65M | -$1.48M | -$14.35M | -$1.28M | -$27.10M |
| **Net Income** | -$645K | -$699K | -$2.29M | $5.25M | -$1.47M | -$14.35M | -$1.27M | -$27.11M |
| Basic EPS | -$0.08 | -$0.13 | -$0.26 | -- | -$1.52 | -$15.07 | -$1.40 | -- |
| **Diluted EPS** | -$0.08 | -$0.13 | -$0.26 | -- | -$1.52 | -$15.07 | -$1.40 | -- |
| Basic Shares Outstanding | 8.5M | 8.4M | 8.4M | -- | 965.6K | 954.1K | 944.5K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.0K | $2.00M | $1.0K | $2.0K |
| **Cash & Short-Term Investments** | $3.0K | $2.00M | $1.0K | $2.0K |
| Accounts Receivable, Net | $5.0K | $201K | $0 | -- |
| Inventory | $63K | -- | -- | -- |
| **Total Current Assets** | $411K | $2.45M | $332K | $122K |
| Property, Plant & Equipment, Net | -- | $17K | $287K | $276K |
| Goodwill | -- | $25.09M | $25.09M | $25.09M |
| Intangible Assets | $16.99M | $17.81M | $18.92M | $20.03M |
| **Total Non-Current Assets** | $16.99M | $17.84M | $44.30M | $46.38M |
| **Total Assets** | $17.41M | $20.29M | $44.63M | $46.50M |
| Accounts Payable | $347K | $314K | $832K | $539K |
| Other Current Liabilities | $621K | $399K | -- | -- |
| **Total Current Liabilities** | $1.16M | $9.79M | $13.14M | $10.59M |
| **Total Non-Current Liabilities** | $688K | $3.27M | $3.23M | $3.23M |
| **Total Liabilities** | $1.85M | $13.05M | $16.37M | $13.83M |
| Common Stock | $105K | $11K | $10K | $70K |
| Retained Earnings | -$49.51M | -$37.67M | -$12.96M | -$8.62M |
| **Total Stockholders' Equity** | $12.31M | $4.26M | $25.22M | $29.56M |
| Total Equity | $15.55M | $7.24M | $28.26M | $32.67M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $21K | $10K | $20K | $3.0K | $12K | $624K | $1.32M | $2.00M |
| **Cash & Short-Term Investments** | $21K | $10K | $20K | $3.0K | $12K | $624K | $1.32M | $2.00M |
| Accounts Receivable, Net | -- | -- | -- | $5.0K | $15K | $200K | $4.0K | $201K |
| Inventory | $56K | $62K | $63K | $63K | $485K | $486K | $489K | -- |
| **Total Current Assets** | $102K | $320K | $377K | $411K | $917K | $1.48M | $2.18M | $2.45M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | $13K | $14K | $16K | $17K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | $25.09M |
| Intangible Assets | $16.14M | $16.43M | $16.71M | $16.99M | $17.28M | $17.57M | $17.85M | $17.81M |
| **Total Non-Current Assets** | $16.32M | $16.43M | $16.71M | $16.99M | $17.29M | $17.58M | $17.87M | $17.84M |
| **Total Assets** | $16.43M | $16.75M | $17.09M | $17.41M | $18.21M | $19.06M | $20.05M | $20.29M |
| Accounts Payable | $450K | $467K | $374K | $347K | $576K | $554K | $615K | $314K |
| Other Current Liabilities | $1.62M | $1.33M | $1.10M | $621K | -- | -- | -- | $399K |
| **Total Current Liabilities** | $2.37M | $2.04M | $1.69M | $1.16M | $23.79M | $23.17M | $9.97M | $9.79M |
| **Total Non-Current Liabilities** | $688K | $688K | $688K | $688K | $3.27M | $3.27M | $3.27M | $3.27M |
| **Total Liabilities** | $3.06M | $2.73M | $2.38M | $1.85M | $27.06M | $26.44M | $13.24M | $13.05M |
| Common Stock | $108K | $108K | $108K | $105K | $12K | $12K | $12K | $11K |
| Retained Earnings | -$53.14M | -$52.49M | -$51.79M | -$49.51M | -$54.75M | -$53.28M | -$38.94M | -$37.67M |
| **Total Stockholders' Equity** | $10.12M | $10.77M | $11.46M | $12.31M | -$11.81M | -$10.34M | $3.84M | $4.26M |
| Total Equity | $13.37M | $14.01M | $14.71M | $15.55M | -$8.85M | -$7.38M | $6.81M | $7.24M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$11.87M | -$24.77M | -$4.41M | -$7.25M |
| Depreciation & Amortization | $1.15M | $1.12M | $1.12M | $1.11M |
| Stock-Based Compensation | $13K | $19K | -- | -- |
| Change in Receivables | -$1.0K | $128K | -- | -- |
| Change in Inventory | $7.0K | -- | -- | -- |
| Change in Payables | $470K | -$436K | $293K | $424K |
| **Operating Cash Flow** | -$1.89M | -$2.85M | -$2.85M | -$2.24M |
| **Investing Cash Flow** | $3.0K | $2.0K | -$15K | -$349K |
| Common Stock Issued | -- | $3.73M | -- | -- |
| **Financing Cash Flow** | -$109K | $4.85M | $2.87M | $2.55M |
| **Net Change in Cash** | -$2.00M | $2.00M | -$1.0K | -$44K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$644K | -$700K | -$2.28M | $5.24M | -$1.48M | -$14.35M | -$1.28M | -$27.13M |
| Depreciation & Amortization | $284K | $284K | $285K | $286K | $288K | $288K | $283K | $279K |
| Stock-Based Compensation | $0 | $0 | $1.44M | $8.0K | $1.0K | $2.0K | $2.0K | -- |
| Change in Receivables | $0 | $0 | $5.0K | -- | -- | -- | -- | -- |
| Change in Payables | -$17K | $93K | $27K | $607K | $22K | -$61K | -$98K | -$605K |
| **Operating Cash Flow** | $11K | $470K | -$464K | $99K | -$613K | -$694K | -$682K | -$986K |
| **Investing Cash Flow** | $0 | $2.0K | -$1.0K | $1.0K | $1.0K | $0 | $1.0K | -- |
| **Financing Cash Flow** | -- | -- | $482K | -- | -- | -- | -- | $317K |
| **Net Change in Cash** | $11K | -$10K | $17K | -$9.0K | -$612K | -$694K | -$681K | -$669K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | -1225.0% | -- | -- | -- |
| **Operating Margin** | -13381.2% | -- | -- | -6808.0% |
| **Net Profit Margin** | -36993.8% | -- | -- | -14510.0% |
| Return on Equity (ROE) | -96.2% | -580.1% | -17.2% | -24.5% |
| Return on Assets (ROA) | -68.0% | -121.8% | -9.7% | -15.6% |
| Current Ratio | 0.35x | 0.25x | 0.03x | 0.01x |
| Quick Ratio | 0.30x | 0.22x | 0.00x | 0.00x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 16.0% | 7.3% | -112.2% | -96.2% | -- | -- | -651.0% | -580.2% |
| Return on Assets (ROA) | 9.8% | 4.7% | -75.3% | -68.0% | -242.7% | -201.9% | -124.8% | -121.8% |
| Current Ratio | 0.04x | 0.16x | 0.22x | 0.35x | 0.04x | 0.06x | 0.22x | 0.25x |
| Quick Ratio | 0.02x | 0.13x | 0.19x | 0.30x | 0.02x | 0.04x | 0.17x | 0.22x |
| **Revenue Growth (YoY)** | +16.7% | -57.1% | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -11.8% | -66.7% | -- | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -134.6% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -132.2% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
